Brind.

Renaissance Technologies lifted its stake in Emergent BioSolutions on August 7, 2026.

1 report, 1 independent Updated Aug 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Renaissance Technologies Emergent BioSolutions

Keep exploring

The entities involved

Renaissance Technologies
American hedge fund firm
- Renaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.Sun 19:54
- A company acquired a new position in Freeport-McMoRan shares, leading to required 13F filings with the SEC on June 6, 2026.Sun 19:14
Emergent BioSolutions
multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
- Emergent BioSolutions and Precigen are two healthcare companies that are currently competing for investment.Sat 00:43

Related events

Coverage

Newest first; wire copies grouped

Aug 7themarketsdaily.com